<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><issn pub-type="epub">3033-8344</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2024-5-2-6-16</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-486</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Апикальная гипертрофическая кардиомиопатия</article-title><trans-title-group xml:lang="en"><trans-title>Apical hypertrophic cardiomyopathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3984-8482</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарадин</surname><given-names>Г. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Taradin</surname><given-names>G. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тарадин Геннадий Геннадьевич - кандидат мед.наукк.м.н., доцент, заведующий кафедрой терапии им. проф. А.И. Дядыка.</p><p>Донецк</p></bio><bio xml:lang="en"><p>Gennady G. Taradin - Candidate of Medical Sciences, Associate Professor, Head of the Department of Therapy named after Prof. A.I. Dyadyk the Faculty of Continuing Medical and Pharmaceutic Education.</p><p>Donetsk</p></bio><email xlink:type="simple">taradin@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3611-1186</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Игнатенко</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ignatenko</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ректор, кафедра пропедевтики</p><p>Игнатенко Григорий Анатольевич, д.м.н., профессор, член-корреспондент НАМНУ, ректор.</p><p>Донецк</p><p>внутренних болезней, заведующий</p></bio><bio xml:lang="en"><p>Grigory A. Ignatenko - Doctor of Medical Sciences, Professor, Corresponding Member of NAMSU, Rector.</p><p>Donetsk</p></bio><email xlink:type="simple">gai-1959@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5547-6741</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куглер</surname><given-names>Т. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kugler</surname><given-names>T. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куглер Татьяна Евгеньевна - к.м.н., доцент кафедры терапии им. проф. А.И. Дядыка.</p><p>Донецк</p></bio><bio xml:lang="en"><p>Tatyana E. Kugler - Candidate of Medical Sciences, Associate Professor of the Department of Therapy named after Prof. A.I. Dyadyk the Faculty of Continuing Medical and Pharmaceutic Education.</p><p>Donetsk</p></bio><email xlink:type="simple">kugler2@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-4530-1861</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марушкин</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Marushkin</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марушкин Никита Сергеевич - врач-ординатор кафедры терапии им. проф. А.И. Дядыка.</p><p>Донецк</p></bio><bio xml:lang="en"><p>Nikita S. Marushkin - Resident of the Department of Therapy named after Prof. A.I. Dyadyk the Faculty of Continuing Medical and Pharmaceutic Education.</p><p>Donetsk</p></bio><email xlink:type="simple">marushkinn@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-5541-2616</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ефанов</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Yefanov</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ефанов Кирилл Игоревич, врач-ординатор кафедры терапии им. проф. А.И. Дядыка.</p><p>Донецк</p></bio><bio xml:lang="en"><p>Kirill I. Efanov - Resident of the Department of Therapy named after Prof. A.I. Dyadyk the Faculty of Continuing Medical and Pharmaceutic Education.</p><p>Donetsk</p></bio><email xlink:type="simple">young_teterev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Донецкий государственный медицинский университет им. М. Горького» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Donetsk State Medical University n. a. M. Gorky, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>11</day><month>06</month><year>2024</year></pub-date><volume>5</volume><issue>2</issue><fpage>6</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тарадин Г.Г., Игнатенко Г.А., Куглер Т.Е., Марушкин Н.С., Ефанов К.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Тарадин Г.Г., Игнатенко Г.А., Куглер Т.Е., Марушкин Н.С., Ефанов К.И.</copyright-holder><copyright-holder xml:lang="en">Taradin G.G., Ignatenko G.A., Kugler T.E., Marushkin N.S., Yefanov K.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/486">https://www.therapeutic-j.ru/jour/article/view/486</self-uri><abstract><p>Обзор посвящёен апикальной гипертрофической кардиомиопатии (ГКМП), представляющей относительно редкий её фенотип. Ранее считалось, что апикальная ГКМП имеет благоприятный прогноз, но недавние исследования продемонстрировали повышенный риск развития фатальных аритмий и внезапной сердечной смерти, особенно среди пожилых пациентов, женщин и имеющих сопутствующиеую патологиию, такиеую как артериальнаяую гипертензияю и сахарный диабет. Апикальная ГКМП чаще регистрируется в странах Азии, хотя тяжёелое течение и неблагоприятные исходы нередко наблюдаются у пациентов стран Европы и Северной Америки. Данный фенотип характеризуется гипертрофией миокарда верхушки сердца, что приводит к уменьшению полости левого желудочка, снижению ударного объёма и диастолической дисфункции. Больные с апикальной ГКМП обычно предъявляют жалобы на боль в грудной клетке, одышку и сердцебиение. Диагноз основывается на данных различных методов исследования, среди которых решающее значение отводится методам визуализации, таким как эхокардиография и магнитно-резонансная томография сердца. Для апикальной ГКМП характерным признаком считается выявление конфигурации полости левого желудочка в конце систолы по типу карточной масти «пики». Лечение включает фармакотерапию с использованием β-адреноблокаторов, блокаторов кальциевых каналов, ингибиторов кардиального миозина и хирургические вмешательства. Недостаточность информации о неблагоприятных прогностических факторах, отсутствие специфических клинических данных и сложности инструментальной диагностики подчеркивают актуальность изучения проблемы апикальной ГКМП.</p></abstract><trans-abstract xml:lang="en"><p>The review provides information about apical hypertrophic cardiomyopathy (HCM), which is a relatively rare phonotype of HCM. Previously, it was believed that apical HCMP has a favorable prognosis, but recent studies have demonstrated an increased risk of fatal arrhythmias and sudden cardiac death, especially among elderly patients, women and those with comorbidities such as arterial hypertension and diabetes mellitus. Patients with apical HCMP complain of chest pain, shortness of breath and palpitations. The diagnosis is based on data from various investigation methods, among which imaging techniques such as echocardiography and cardiac magnetic resonance imaging are crucial. For apical HCMP, a characteristic sign is the identification of the configuration of the left ventricular cavity at the end of the systole resembling to the type "Ace-of-spades". Treatment includes pharmacotherapy using beta-blockers, calcium channel blockers, cardiac myosin inhibitors and surgical interventions. The lack of information on unfavorable prognostic factors, the lack of specific clinical data and the complexity of instrumental diagnosis emphasize the relevance of studying the problem of apical HCMP.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гипертрофическая кардиомиопатия</kwd><kwd>апикальная</kwd><kwd>фенотип</kwd><kwd>аневризма</kwd><kwd>эхокардиография</kwd><kwd>внезапная сердечная смерть</kwd><kwd>миоэктомия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertrophic cardiomyopathy</kwd><kwd>apical</kwd><kwd>phenotype</kwd><kwd>aneurysm</kwd><kwd>echocardiography</kwd><kwd>sudden cardiac death</kwd><kwd>myectomy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. European Heart Journal. 2014;35(39):2733-2779. DOI: 10.1093/eurheartj/ehu284</mixed-citation><mixed-citation xml:lang="en">Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. European Heart Journal. 2014;35(39):2733-2779. DOI: 10.1093/eurheartj/ehu284</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation. 2020;142(25):e533-e557. DOI: 10.1161/CIR.0000000000000938</mixed-citation><mixed-citation xml:lang="en">Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation. 2020;142(25):e533-e557. DOI: 10.1161/CIR.0000000000000938</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Габрусенко С. А., Гудкова А. Я., Козиолова Н. А., Александрова С. А., Берсенева М. И., Гордеев М. Л., и др. Гипертрофическая кардиомиопатия. Клинические рекомендации. РКЖ. 2021; 26(5):4541. DOI: 10.15829/1560-4071-2021-4541</mixed-citation><mixed-citation xml:lang="en">Gabrusenko S. A., Gudkova A. Ya., Koziolova N. A., Alexandrova S. A., Berseneva M. I., Gordeev M. L., et al. Hypertrophic cardiomyopathy. Clinical recommendations. Russian Journal of Cardiology. 2021;26(5):4541 (In Russ.) DOI: 10.15829/1560-4071-2021-4541</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко Г.А., Тарадин Г.Г., Куглер Т.Е. Особенности гипертрофии левого желудочка и характеристика фенотипических вариантов у больных гипертрофической кардиомиопатией. Архивъ внутренней медицины. 2023;13(4):282-293. DOI: 10.20514/2226-6704-2023-13-4-282-293</mixed-citation><mixed-citation xml:lang="en">. Ignatenko G.A., Taradin G.G., Kugler T.E. Features of left ventricular hypertrophy and characteristics of phenotypic variants in patients with hypertrophic cardiomyopathy. Archive of Internal Medicine. 2023;13(4):282-293. (In Russ.) DOI: 10.20514/2226-6704-2023-13-4-282-293</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound. 2016;14(1):30. DOI: 10.1186/s12947-016-0072-5.</mixed-citation><mixed-citation xml:lang="en">Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M, et al. Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound. 2016;14(1):30. DOI: 10.1186/s12947-016-0072-5.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Стрельцова А.А., Гудкова А.Я. Апикальная гипертрофическая кардиомиопатия: современные представления о распространенности, клинической картине, диагностике и лечении (обзор литературы). Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова. 2021;28(1):17-22. DOI: 10.24884/1607-4181-2021-28-1-17-22</mixed-citation><mixed-citation xml:lang="en">Streltsova A.A., Gudkova A.Ya. Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature). The Scientific Notes of the Pavlov University. 2021;28(1):17-22. (In Russ.) DOI: 10.24884/1607-4181-2021-28-1-17-22</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Гончарова Д.Ю., Бикбаева Г.Р., Тухбатова А.А., Муллова И.С., Дупляков Д.В. Апикальная гипертрофическая кардиомиопатия как маска острого коронарного синдрома. Клинические наблюдения. Российский кардиологический журнал. 2022;27(4S):5262. DOI: 10.15829/1560-4071-2022-5262</mixed-citation><mixed-citation xml:lang="en">Goncharova D.Yu., Bikbaeva G.R., Tukhbatova A.A., Mullova I.S., Duplyakov D.V. Apical hypertrophic cardiomyopathy as a mask of acute coronary syndrome. Clinical observations. Russian Journal of Cardiology. 2022;27(4S):5262. (In Russ.) DOI: 10.15829/1560-4071-2022-5262</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Raza N, Burnette S, Joolhar FS, Ghandforoush A, Win TT. A giant left intraventricular thrombus associated with apical hypertrophic cardiomyopathy mimics cancer. Cureus. 2021 Jun 9;13(6):e15554. DOI: 10.7759/cureus.15554.</mixed-citation><mixed-citation xml:lang="en">Raza N, Burnette S, Joolhar FS, Ghandforoush A, Win TT. A giant left intraventricular thrombus associated with apical hypertrophic cardiomyopathy mimics cancer. Cureus. 2021 Jun 9;13(6):e15554. DOI: 10.7759/cureus.15554.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Caiati C, Stanca A, Lepera ME. Case report: Diagnosis of apical hypertrophic cardiomyopathy that escaped clinical and echocardiographic investigations for twenty years: Reasons and clinical implications. Front Cardiovasc Med. 2023 Apr 24;10:1157599. DOI: 10.3389/fcvm.2023.1157599.</mixed-citation><mixed-citation xml:lang="en">Caiati C, Stanca A, Lepera ME. Case report: Diagnosis of apical hypertrophic cardiomyopathy that escaped clinical and echocardiographic investigations for twenty years: Reasons and clinical implications. Front Cardiovasc Med. 2023 Apr 24;10:1157599. DOI: 10.3389/fcvm.2023.1157599.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Скопецкая С.А., Леонтьева Т.В., Мусуривская Т.В., Серебрянникова О.С. Диагностика и лечение апикальной гипертрофической кардиомиопатии левого желудочка. Кардиология. 2022;62(2):42–46. DOI: 10.18087/cardio.2022.2.n1590</mixed-citation><mixed-citation xml:lang="en">Skopetckaya S.A., Leontieva T.V., Musurivskaya T.V., Serebryannikova O.S. Diagnosis and treatment of apical hypertrophic cardiomyopathy of the left ventricle. Kardiologiia. 2022;62(2):42–46. (In Russ.) DOI: 10.18087/cardio.2022.2.n1590</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Чанахчян Ф.Н., Гуляев Н.И., Сливинский Д.В., Клочкова И.В., Шутова Е.В., Демченкова А.Ю. Мультимодальная визуализация в диагностике апикальной гипертрофической кардиомиопатии: клинический случай. Лучевая диагностика и терапия. 2023; 14(3):93–98. DOI: 10.22328/2079-5343-2023-14-3-93-98.</mixed-citation><mixed-citation xml:lang="en">Chanakhchian F.N., Gulyaev N.I., Slivinski D.V., Klochkova I.V., Shutova E.V., Demchenkova A.Yu. Multimodality imaging in apical hypertrophic cardiomyopathy: clinical case. Diagnostic radiology and radiotherapy. 2023;14(3):93-98. (In Russ.) DOI: 10.22328/2079-5343-2023-14-3-93-98.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Huang G, Fadl SA, Sukhotski S, Matesan M. Apical variant hypertrophic cardiomyopathy “multimodality imaging evaluation”. Int J Cardiovasc Imaging. 2020;36(3):553-561. DOI: 10.1007/s10554-019-01739-x</mixed-citation><mixed-citation xml:lang="en">. Huang G, Fadl SA, Sukhotski S, Matesan M. Apical variant hypertrophic cardiomyopathy “multimodality imaging evaluation”. Int J Cardiovasc Imaging. 2020;36(3):553-561. DOI: 10.1007/s10554-019-01739-x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, et al. 2020 Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294. DOI: 10.1161/JAHA.119.01529414.</mixed-citation><mixed-citation xml:lang="en">Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, et al. 2020 Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294. DOI: 10.1161/JAHA.119.01529414.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Fang J., Liu Y., Wei X. Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management. Clin Res Cardiol. 2024;113(5):680-693. DOI: 10.1007/s00392-023-02328-8 Clin Res Cardiol. 2023 Nov 20. doi: 10.1007/s00392-023-02328-8.</mixed-citation><mixed-citation xml:lang="en">Li J., Fang J., Liu Y., Wei X. Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management. Clin Res Cardiol. 2023. doi:10.1007/s00392-023-02328-8 8.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Teekakirikul P, Zhu W, Huang HC, Fung E. hypertrophic cardiomyopathy: an overview of genetics and management. Biomolecules. 2019 Dec 16;9(12):878. DOI: 10.3390/biom9120878.</mixed-citation><mixed-citation xml:lang="en">Li J., Fang J., Liu Y., Wei X. Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management. Clin Res Cardiol. 2024;113(5):680-693. DOI: 10.1007/s00392-023-02328-8 Clin Res Cardiol. 2023 Nov 20. doi: 10.1007/s00392-023-02328-8.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, et al. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS One. 2017;12(11):e0187948. DOI: 10.1371/journal.pone.0187948</mixed-citation><mixed-citation xml:lang="en">Teekakirikul P, Zhu W, Huang HC, Fung E. hypertrophic cardiomyopathy: an overview of genetics and management. Biomolecules. 2019 Dec 16;9(12):878. DOI: 10.3390/biom9120878.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011; 58(25): e212-e260. DOI: 10.1016/j.jacc.2011.06.011</mixed-citation><mixed-citation xml:lang="en">Viswanathan SK, Sanders HK, McNamara JW, Jagadeesan A, Jahangir A, Tajik AJ, et al. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS One. 2017;12(11):e0187948. DOI: 10.1371/journal.pone.0187948</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Jan MF, Todaro MC, Oreto L, Tajik AJ. Apical hypertrophic cardiomyopathy: Present status. Int J Cardiol. 2016;222:745-759. DOI: 10.1016/j.ijcard.2016.07.154</mixed-citation><mixed-citation xml:lang="en">. Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011; 58(25): e212-e260. DOI: 10.1016/j.jacc.2011.06.011</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Paluszkiewicz J, Krasinska B, Milting H, Gummert J, Pyda M. Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment. Kardiochir Torakochirurgia Pol. 2018;15(4):246-253. DOI: 10.5114/kitp.2018.80922</mixed-citation><mixed-citation xml:lang="en">Jan MF, Todaro MC, Oreto L, Tajik AJ. Apical hypertrophic cardiomyopathy: Present status. Int J Cardiol. 2016;222:745-759. DOI: 10.1016/j.ijcard.2016.07.154</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes RK, Knott KD, Malcolmson J, Augusto JB, Kellman P, Moon JC, Captur Get al. Advanced imaging insights in apical hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 2):624-630. DOI: 10.1016/j.jcmg.2019.09.010.</mixed-citation><mixed-citation xml:lang="en">. Paluszkiewicz J, Krasinska B, Milting H, Gummert J, Pyda M. Apical hypertrophic cardiomyopathy: diagnosis, medical and surgical treatment. Kardiochir Torakochirurgia Pol. 2018;15(4):246-253. DOI: 10.5114/kitp.2018.80922</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ünlü S, Özden Tok Ö, Avcı Demir F, Papadopoulos K, Monaghan MJ. Differential diagnosis of apical hypertrophic cardiomyopathy and apical displacement of the papillary muscles: a multimodality imaging point of view. Echocardiography. 2021;38(1):103-113. DOI: 10.1111/echo.14895</mixed-citation><mixed-citation xml:lang="en">Hughes RK, Knott KD, Malcolmson J, Augusto JB, Kellman P, Moon JC, Captur Get al. Advanced imaging insights in apical hypertrophic cardiomyopathy. JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 2):624-630. DOI: 10.1016/j.jcmg.2019.09.010.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Foucault A, Hilpert L, Hédoire F, Saloux E, Gomes S, Pellissier A, et al. Apical aneurysm and myocardial bridging in a patient with hypertrophic cardiomyopathy: association or consequence of the myocardial bridging? Cardiol J. 2012;19(6):643-645. DOI: 10.5603/cj.2012.0119.</mixed-citation><mixed-citation xml:lang="en">. Ünlü S, Özden Tok Ö, Avcı Demir F, Papadopoulos K, Monaghan MJ. Differential diagnosis of apical hypertrophic cardiomyopathy and apical displacement of the papillary muscles: a multimodality imaging point of view. Echocardiography. 2021;38(1):103-113. DOI: 10.1111/echo.14895</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yan L, Wang Z, Xu Z, Li Y, Tao Y, Fan C. Two hundred eight patients with apical hypertrophic cardiomyopathy in China: clinical feature, prognosis, and comparison of pure and mixed forms. Clin Cardiol. 2012 Feb;35(2):101-106. DOI: 10.1002/clc.20995.</mixed-citation><mixed-citation xml:lang="en">Foucault A, Hilpert L, Hédoire F, Saloux E, Gomes S, Pellissier A, et al. Apical aneurysm and myocardial bridging in a patient with hypertrophic cardiomyopathy: association or consequence of the myocardial bridging? Cardiol J. 2012;19(6):643-645. DOI: 10.5603/cj.2012.0119.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. DOI: 10.1016/j.jacc.2021.11.021.</mixed-citation><mixed-citation xml:lang="en">. Yan L, Wang Z, Xu Z, Li Y, Tao Y, Fan C. Two hundred eight patients with apical hypertrophic cardiomyopathy in China: clinical feature, prognosis, and comparison of pure and mixed forms. Clin Cardiol. 2012 Feb;35(2):101-106. DOI: 10.1002/clc.20995.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Huang W, Guan L, Liu L, Mu Y. Apical hypertrophic cardiomyopathy with apical endomyocardial fibrosis and calcification: Two case reports. Medicine (Baltimore). 2019;98(27):e16183. DOI: 10.1097/MD.0000000000016183</mixed-citation><mixed-citation xml:lang="en">. Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Management of hypertrophic cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. DOI: 10.1016/j.jacc.2021.11.021.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kang L, Li YH, Li R, Chu QM. Predicting apical hypertrophic cardiomyopathy using T-wave inversion: Three case reports. World J Clin Cases. 2023 Sep 6;11(25):5970-5976. DOI: 10.12998/wjcc.v11.i25.5970.</mixed-citation><mixed-citation xml:lang="en">. Huang W, Guan L, Liu L, Mu Y. Apical hypertrophic cardiomyopathy with apical endomyocardial fibrosis and calcification: Two case reports. Medicine (Baltimore). 2019;98(27):e16183. DOI: 10.1097/MD.0000000000016183</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK et al. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2013 Jun 15;111(12):1784-1791. DOI: 10.1016/j.amjcard.2013.02.040.</mixed-citation><mixed-citation xml:lang="en">. Kang L, Li YH, Li R, Chu QM. Predicting apical hypertrophic cardiomyopathy using T-wave inversion: Three case reports. World J Clin Cases. 2023 Sep 6;11(25):5970-5976. DOI: 10.12998/wjcc.v11.i25.5970.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna S, Sreedharan R, Maheshwari K, Ruetzler K. Giant T-wave Inversions in Apical Hypertrophic Cardiomyopathy. Anesthesiology. 2019;131(2):398-399. DOI: 10.1097/ALN.0000000000002732</mixed-citation><mixed-citation xml:lang="en">. Klarich KW, Attenhofer Jost CH, Binder J, Connolly HM, Scott CG, Freeman WK et al. Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy. Am J Cardiol. 2013 Jun 15;111(12):1784-1791. DOI: 10.1016/j.amjcard.2013.02.040.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sanghvi NK, Tracy CM. Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol. 2007;30(6):799-803. DOI: 10.1111/j.1540-8159.2007.00753.x</mixed-citation><mixed-citation xml:lang="en">. Khanna S, Sreedharan R, Maheshwari K, Ruetzler K. Giant T-wave Inversions in Apical Hypertrophic Cardiomyopathy. Anesthesiology. 2019;131(2):398-399. DOI: 10.1097/ALN.0000000000002732</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A et al. Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2022 Jun;35(6):533-569. DOI: 10.1016/j.echo.2022.03.012.</mixed-citation><mixed-citation xml:lang="en">. Sanghvi NK, Tracy CM. Sustained ventricular tachycardia in apical hypertrophic cardiomyopathy, midcavitary obstruction, and apical aneurysm. Pacing Clin Electrophysiol. 2007;30(6):799-803. DOI: 10.1111/j.1540-8159.2007.00753.x</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко Г.А., Тарадин Г.Г., Ракитская И.В. Методы визуализации в диагностике гипертрофической кардиомиопатии. Актуальные проблемы медицины. 2023; 46(4): 351–367. DOI: 10.52575/2687-0940-2023-46-4-351-367</mixed-citation><mixed-citation xml:lang="en">. Nagueh SF, Phelan D, Abraham T, Armour A, Desai MY, Dragulescu A et al. Recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2022 Jun;35(6):533-569. DOI: 10.1016/j.echo.2022.03.012.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kim E.K., Lee S.C., Hwang J.W., Chang S. A., Park S.J., On Y.K., et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging. 2016;17(6):678-686. DOI: 10.1093/ehjci/jev192</mixed-citation><mixed-citation xml:lang="en">. Ignatenko G.A., Taradin G.G., Rakitskaya I.V. Imaging methods in the diagnosis of hypertrophic cardiomyopathy. Current Problems of Medicine. 2023; 46(4): 351–367. (In Russ.) DOI: 10.52575/2687-0940-2023-46-4-351-367</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18(10):1074-1082. DOI: 10.1016/j.echo.2005.06.011</mixed-citation><mixed-citation xml:lang="en">. Kim E.K., Lee S.C., Hwang J.W., Chang S. A., Park S.J., On Y.K., et al. Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients. Eur Heart J Cardiovasc Imaging. 2016;17(6):678-686. DOI: 10.1093/ehjci/jev192</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Nakamura T., Matsubara K., Furukawa K., Azuma A., Sugihara H., Katsume H., et al. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol. 1992;19(3):516-524. DOI: 10.1016/s0735-1097(10)80264-5</mixed-citation><mixed-citation xml:lang="en">. Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18(10):1074-1082. DOI: 10.1016/j.echo.2005.06.011</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Amano Y, Kitamura M, Takano H, Yanagisawa F, Tachi M, Suzuki Y et al. Cardiac MR imaging of hypertrophic cardiomyopathy: techniques, findings, and clinical relevance. Magn Reson Med Sci. 2018;17(2):120–131. DOI: 10.2463/mrms.rev.2017-0145</mixed-citation><mixed-citation xml:lang="en">. Nakamura T., Matsubara K., Furukawa K., Azuma A., Sugihara H., Katsume H., et al. Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol. 1992;19(3):516-524. DOI: 10.1016/s0735-1097(10)80264-5</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Baxi A.J., Restrepo C.S., Vargas D., Marmol-Velez A., Ocazionez D., Murillo H. Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics. 2016;36(2):335-354. DOI: 10.1148/rg.2016150137</mixed-citation><mixed-citation xml:lang="en">. Amano Y, Kitamura M, Takano H, Yanagisawa F, Tachi M, Suzuki Y et al. Cardiac MR imaging of hypertrophic cardiomyopathy: techniques, findings, and clinical relevance. Magn Reson Med Sci. 2018;17(2):120–131. DOI: 10.2463/mrms.rev.2017-0145</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Yin Y, Hu W, Zhang L, Wu D, Yang C, Ye X. Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2022 Mar;38(3):643-651. DOI: 10.1007/s10554-021-02430-w.</mixed-citation><mixed-citation xml:lang="en">. Baxi A.J., Restrepo C.S., Vargas D., Marmol-Velez A., Ocazionez D., Murillo H. Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics. 2016;36(2):335-354. DOI: 10.1148/rg.2016150137</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Yang K, Song YY, Chen XY, Wang JX, Li L, Yin G et al. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: prevalence, cardiac magnetic resonance characteristics, and prognosis. Eur Heart J Cardiovasc Imaging. 2020 Dec 1;21(12):1341-1350. DOI: 10.1093/ehjci/jeaa246.</mixed-citation><mixed-citation xml:lang="en">. Yin Y, Hu W, Zhang L, Wu D, Yang C, Ye X. Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2022 Mar;38(3):643-651. DOI: 10.1007/s10554-021-02430-w.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118(15):1541-9. DOI: 10.1161/CIRCULATIONAHA.108.781401.</mixed-citation><mixed-citation xml:lang="en">. Yang K, Song YY, Chen XY, Wang JX, Li L, Yin G et al. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: prevalence, cardiac magnetic resonance characteristics, and prognosis. Eur Heart J Cardiovasc Imaging. 2020 Dec 1;21(12):1341-1350. DOI: 10.1093/ehjci/jeaa246.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Narula J, Chandrashekhar Y, Ahmadi A, Abbara S, Berman DS, Blankstein R et al. SCCT 2021 Expert Consensus Document on coronary computed tomographic angiography. J Cardiovasc Comput Tomogr .2021;15(3):192–217. DOI: 10.1016/j.jcct.2020.11.001</mixed-citation><mixed-citation xml:lang="en">. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118(15):1541-9. DOI: 10.1161/CIRCULATIONAHA.108.781401.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Mowatt G, Cook JA, Hillis GS, Walker S, Fraser C, Jia X et al. 64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart. 2008; 94(11):1386–1393. DOI: 10.1136/hrt.2008.145292</mixed-citation><mixed-citation xml:lang="en">. Narula J, Chandrashekhar Y, Ahmadi A, Abbara S, Berman DS, Blankstein R et al. SCCT 2021 Expert Consensus Document on coronary computed tomographic angiography. J Cardiovasc Comput Tomogr .2021;15(3):192–217. DOI: 10.1016/j.jcct.2020.11.001</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi R., Mirabella F., Secco G.G, Fattori R. Multimodality imaging in apical hypertrophic cardiomyopathy. World J Cardiol. 2014;6(9):916-923. DOI: 10.4330/wjc.v6.i9.916</mixed-citation><mixed-citation xml:lang="en">. Mowatt G, Cook JA, Hillis GS, Walker S, Fraser C, Jia X et al. 64-Slice computed tomography angiography in the diagnosis and assessment of coronary artery disease: systematic review and meta-analysis. Heart. 2008; 94(11):1386–1393. DOI: 10.1136/hrt.2008.145292</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Morishita S., Kondo Y., Nomura M., Miyajima H., Nada T., Ito S., et al. Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol. 2001;87(6):743-747. DOI: 10.1016/s0002-9149(00)01494-6</mixed-citation><mixed-citation xml:lang="en">. Parisi R., Mirabella F., Secco G.G, Fattori R. Multimodality imaging in apical hypertrophic cardiomyopathy. World J Cardiol. 2014;6(9):916-923. DOI: 10.4330/wjc.v6.i9.916</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ward R.P., Pokharna H.K., Lang R.M., Williams K.A. Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging. J Nucl Cardiol. 2003;10(5):506-512. DOI: 10.1016/s1071-3581(03)00455-0</mixed-citation><mixed-citation xml:lang="en">. Morishita S., Kondo Y., Nomura M., Miyajima H., Nada T., Ito S., et al. Impaired retention of technetium-99m tetrofosmin in hypertrophic cardiomyopathy. Am J Cardiol. 2001;87(6):743-747. DOI: 10.1016/s0002-9149(00)01494-6</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cianciulli TF, Saccheri MC, Masoli OH, Redruello MF, Lax JA, Morita LA, et al. Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol. 2009 May-Jun;16(3):391-395. DOI: 10.1007/s12350-008-9045-x.</mixed-citation><mixed-citation xml:lang="en">. Ward R.P., Pokharna H.K., Lang R.M., Williams K.A. Resting "Solar Polar" map pattern and reduced apical flow reserve: characteristics of apical hypertrophic cardiomyopathy on SPECT myocardial perfusion imaging. J Nucl Cardiol. 2003;10(5):506-512. DOI: 10.1016/s1071-3581(03)00455-0</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Jenab Y, Pourjafari M, Darabi F, Boroumand MA, Zoroufian A, Jalali A. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Cardiol. 2014 Feb;63(2):140-144. DOI: 10.1016/j.jjcc.2013.07.008.</mixed-citation><mixed-citation xml:lang="en">. Cianciulli TF, Saccheri MC, Masoli OH, Redruello MF, Lax JA, Morita LA, et al. Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy. J Nucl Cardiol. 2009 May-Jun;16(3):391-395. DOI: 10.1007/s12350-008-9045-x.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко Г.А., Тарадин Г.Г., Кононенко Л.В. Фармакотерапия гипертрофической кардиомиопатии. Южно-Российский журнал терапевтической практики. 2023;4(4):6-13. DOI: 10.21886/2712-8156-2023-4-4-6-13</mixed-citation><mixed-citation xml:lang="en">Jenab Y, Pourjafari M, Darabi F, Boroumand MA, Zoroufian A, Jalali A. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Cardiol. 2014 Feb;63(2):140-144. DOI: 10.1016/j.jjcc.2013.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Doctorian T., Mosley W.J., Do B. Apical hypertrophic cardiomyopathy: case report and literature review. Am J Case Rep. 2017 May 12;18:525-528. DOI: 10.12659/ajcr.902774.</mixed-citation><mixed-citation xml:lang="en">. Ignatenko G.A., Taradin G.G., Kononenko L.V. Pharmacotherapy of hypertrophic cardiomyopathy. South Russian Journal of Therapeutic Practice. 2023;4(4):6-13. (In Russ.) DOI: 10.21886/2712-8156-2023-4-4-6-13</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Force M, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the ESC. Eur J Heart Fail. 2016;18(8):891-975. DOI: 10.1002/ejhf.592.</mixed-citation><mixed-citation xml:lang="en">Doctorian T., Mosley W.J., Do B. Apical hypertrophic cardiomyopathy: case report and literature review. Am J Case Rep. 2017 May 12;18:525-528. DOI: 10.12659/ajcr.902774.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Samak M., Fatullayev J., Sabashnikov A., Zeriouh M., Schmack B., Farag M., et al. Cardiac hypertrophy: An introduction to molecular and cellular basis. Medical science monitor basic research. 2016;22:75-79. DOI: 10.12659/MSMBR.900437</mixed-citation><mixed-citation xml:lang="en">. Force M, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the ESC. Eur J Heart Fail. 2016;18(8):891-975. DOI: 10.1002/ejhf.592.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Saitoh D., Saji M., Takanashi S. Extended myectomy for apical hypertrophic cardiomyopathy: a case report. J Cardiothorac Surg. 2021;16(1):360. DOI: 10.1186/s13019-021-01745-y</mixed-citation><mixed-citation xml:lang="en">Samak M., Fatullayev J., Sabashnikov A., Zeriouh M., Schmack B., Farag M., et al. Cardiac hypertrophy: An introduction to molecular and cellular basis. Medical science monitor basic research. 2016;22:75-79. DOI: 10.12659/MSMBR.900437</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Kotkar K.D., Said S.M., Schaff H.V. Transapical approach for myectomy in hypertrophic cardiomyopathy. Ann Cardiothorac Surg. 2017;6(4):419-422. DOI: 10.21037/acs.2017.06.02</mixed-citation><mixed-citation xml:lang="en">. Saitoh D., Saji M., Takanashi S. Extended myectomy for apical hypertrophic cardiomyopathy: a case report. J Cardiothorac Surg. 2021;16(1):360. DOI: 10.1186/s13019-021-01745-y</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Afanasyev A, Bogachev-Prokophiev A, Zheleznev S, Ovcharov M, Zalesov A, Sharifulin R, et al. Transapical approach to septal myectomy for hypertrophic cardiomyopathy. Life (Basel). 2024 Jan 15;14(1):125. DOI: 10.3390/life14010125.</mixed-citation><mixed-citation xml:lang="en">. Kotkar K.D., Said S.M., Schaff H.V. Transapical approach for myectomy in hypertrophic cardiomyopathy. Ann Cardiothorac Surg. 2017;6(4):419-422. DOI: 10.21037/acs.2017.06.02</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, et al. Enhanced American College of Cardiology/American Heart Association Strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2019 Jul 1;4(7):644-657. DOI: 10.1001/jamacardio.2019.1391.</mixed-citation><mixed-citation xml:lang="en">. Afanasyev A, Bogachev-Prokophiev A, Zheleznev S, Ovcharov M, Zalesov A, Sharifulin R, et al. Transapical approach to septal myectomy for hypertrophic cardiomyopathy. Life (Basel). 2024 Jan 15;14(1):125. DOI: 10.3390/life14010125.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, et al. Enhanced American College of Cardiology/American Heart Association Strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2019 Jul 1;4(7):644-657. DOI: 10.1001/jamacardio.2019.1391.</mixed-citation><mixed-citation xml:lang="en">Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, et al. Enhanced American College of Cardiology/American Heart Association Strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2019 Jul 1;4(7):644-657. DOI: 10.1001/jamacardio.2019.1391.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
